Japan’s Takeda bets on dengue vax to reshape India playbook

Takeda Pharmaceutical’s new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027. It will initially be available through the private market for individuals. Takeda plans to pursue government procurement and National Immunisation Programme inclusion. This move significantly broadens Takeda’s public health focus in India.

Value meals, store traffic drive QSR chains’ recovery

Restaurant chains experienced a significant recovery in the April-June quarter. Value growth and expansion into smaller cities drove this positive trend. Higher in-store traffic and improved daily sales contributed to the recovery. Chains are focusing on value meals and selective price adjustments. This marks a reversal after several quarters of declining sales and profits.

Airtel Q1 Net Up 35% on Postpaid, Data User Surge

Bharti Airtel reported a 35.45% year-on-year net profit increase for the June quarter. This growth was fueled by strong performance in its India mobile operations and Africa business. The company achieved record postpaid net additions and saw growing smartphone data customers. Bharti Airtel’s average revenue per user reached the sector’s highest at ₹264. Consolidated revenue…